COMPLETED

Patient Decision Aid for Opioid Use Disorder

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The aim of the study is to test the effectiveness of the Patient Decision Aid for Opioid Use Disorder (PtDA-MAT) by conducting a stepped-wedge cluster-randomized trial in CA H\&SS (stratified by rural vs. non-rural areas) for adults with OUD. Patient outcomes will be tracked by (1) personal assessments (baseline, 3 months, and 6 months): drug use, overdose, healthcare utilization, and (2) clinical and administrative records (over approximately 24 months): drug treatment status and retention, physical and mental health diagnoses, arrest, incarceration, controlled substance use, and mortality. Multilevel models will be applied to test the intervention effects, controlling for possible temporal trends.

Official Title

Patient Decision Aid for Medication-Assisted Treatment for Opioid Use Disorder

Quick Facts

Study Start:2020-08-03
Study Completion:2024-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT03568552

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Opioid Use Disorder diagnosis and agreement to follow study procedures (including permission to share medical records and other administrative records)
  1. * Significant or unstable medical or psychiatric illness that may interfere with study participation

Contacts and Locations

Principal Investigator

Yih-Ing Hser, Ph.D.
PRINCIPAL_INVESTIGATOR
University of California, Los Angeles
Larissa Mooney, M.D.
PRINCIPAL_INVESTIGATOR
University of California, Los Angeles

Study Locations (Sites)

UCLA Integrated Substance Abuse Programs
Los Angeles, California, 90049
United States

Collaborators and Investigators

Sponsor: University of California, Los Angeles

  • Yih-Ing Hser, Ph.D., PRINCIPAL_INVESTIGATOR, University of California, Los Angeles
  • Larissa Mooney, M.D., PRINCIPAL_INVESTIGATOR, University of California, Los Angeles

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-08-03
Study Completion Date2024-08-31

Study Record Updates

Study Start Date2020-08-03
Study Completion Date2024-08-31

Terms related to this study

Keywords Provided by Researchers

  • Opioid Use Disorder (OUD)
  • Medication Assisted Therapy (MAT)
  • Patient Decision Aid
  • Medication Treatment for Opioid Use Disorder (MOUD)

Additional Relevant MeSH Terms

  • Opioid Use Disorder